Streptococcus pneumoniae is an alpha-hemolytic, grampositive diplococcus and is easily differentiated from other alpha-hemolytic streptococci by its susceptibility to optochin. All 84 serotypes are pathogenic for humans. Pneumococcal infections have been documented in animals (6, 12) , but this pathogen has received no attention in veterinary microbiology texts (4, 5, 8, 13) .
Pneumococci are normal residents of the upper respiratory tracts of humans, with the carrier state ranging from 5 to 60%, depending on immediate environmental conditions and season (2) . The upper respiratory disease induced by pneumococci is a well-defined clinical and pathological entity.
Pneumococcal infection in horses has not been reported in recent years, although a number of cases were reported during the early 1900s and have been summarized in a monograph on Streptococcus infections by Romer (12) . These early reports were questioned because of a concern about the reliability and validity of the methodology used to identify the streptococcal species (12) . The early reports present clinical data on foals, with no mention of a pneumococcal infection in adult horses or transmission of the microbe to humans. The most recent report of pneumococcal disease in horses appeared in 1941 (9) and described a pneumococcal septicemia concomitant with joint infections, pneumonia, pleurisy, and pericarditis with enlargement of spleen and liver in a foal. The serotype of the pathogen was not determined.
We have isolated S. pneumoniae type 3 from seven tracheobronchial aspirates and one pleural tap of seven adult horses and one foal that were referred to George D. Widener Hospital, New Bolton Center, University of Pennsylvania, Kennett Square. The type 3 encapsulated organism is one of the most virulent forms of the pneumococcus and produces a lethal infection in humans when left untreated (1). In contrast, acute pneumococcal infection was not obvious in the clinical histories of the horses described in this paper.
MATERIALS AND METHODS
The eight horses were referred to George D. Widener Hospital with different presenting complaints (see Table 1 ) between June 1981 and May 1983. The age range was 3 to 4 years old, except for horse 8 (6 months). The tracheobronchial aspirates and pleural fluid were obtained by routine methods that have been previously described (3, 10) RESULTS AND DISCUSSION The recovery of S. pneilinoniae type 3 in tracheobronchial aspirates of seven horses and in the pleural fluid of one horse during a 2-year period at New Bolton Center was unexpected. Our laboratory receives 320 tracheobronchial and 62 pleural fluid aspirates for culture during an average year. Therefore, it is unlikely that the cultures were contaminated with the pneumococcus by one of the laboratory technicians. Although the different isolates were detected by the same laboratory technician, the plates were initially inoculated by several individuals.
The clinical data is summarized in Table 1 . The variety of respiratory disease symptoms seen in several horses infected by the pneumococcus is in striking contrast to the acute disease of foals (9, 12) and humans (2) . Although there is no direct evidence that isolation of the pneumococcus is related to a specific disease syndrome, the consistent isolation of serotype 3 warrants closer attention. The horses had come from different stables at staggered intervals during the preceding 2 years. A seasonal prevalence was not evident, and thus common sources of contamination or spread were not obvious. We have not found S. pneumoniae in normal healthy horses or in patients with acute respiratory infections.
Two of the eight horses (horses 1 S. pneumoniae type 3 may play a role as a secondary respiratory pathogen which complicates the primary microbial and physiological insult in these horses. We speculate that the type 3 pneumococcal capsular polysaccharide may accumulate in the alveolar spaces and further compromise lung capacity, as well as hinder the normal first-line nonspecific host defense mechanisms, e.g., cough reflex, motion of ciliary epithelium, and alveolar macrophages. Such interaction appears to be the situation in humans (2).
Alternative interpretations include primary infections by pneumococci, which predisposes to colonization by lowvirulence microbes. In this situation, the superinfecting pathogen(s) may either overgrow the initial lesion and displace pneumococci or lead to a respiratory infection with a mixed etiology. The association of the pneumococcus with a specific disease syndrome in horses could represent nothing more than a transient infection with no overt clinical symptoms. In any instance, exposure of humans to equine pneumococcal carriers represents cause for concern for crossspecies inoculation of the human contact. We did not have the opportunity to screen the handlers, trainers, or owners of the horses described in this study to determine a human carrier. The consistency of the isolate type is unexplained. On the basis of the volume of aerobic blood cultures initiated daily in our laboratory, it would be extremely difficult to understand how the tracheobronchial aspirate of only those horses with chronic cough would be contaminated with S. pneumoniae. The low incidence of recovery of S. pneumoniae (three to five cases per year) compared with the human carrier rate suggests that these horses acquired the infecting agent from a human source rather than that the horses served as the reservoir for human infections (2) . The horses had come from a variety of farms, and there was no common contact, according to trainers, owners, and clinicians. The cases reported in this study were collected during a 2-year 
